InvestorsHub Logo
Followers 32
Posts 5229
Boards Moderated 0
Alias Born 03/25/2013

Re: None

Sunday, 02/11/2018 8:17:05 PM

Sunday, February 11, 2018 8:17:05 PM

Post# of 426485
Question for those Longs with an 80% or higher confidence level that REDUCE-IT produces at least 15% RRR in a couple quarters. What is it that makes you most comfortable about the trial showing Vascepa can make a significant difference in CV health?

Is it JELIS, ANCHOR, another study, script growth, company statements/actions, your own mathematical models using total events over time, analyst comments/forecasts, arguments from fellow Longs, options market, or something else?

I'm curious what drives AMRN investors and lets them sleep well at night when I'm tossing and turning.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News